Literature DB >> 27507199

Phytochemistry and pharmacology of Allii Macrostemonis Bulbus, a traditional Chinese medicine.

Zhi-Hong Yao1, Zi-Fei Qin2, Yi Dai2, Xin-Sheng Yao3.   

Abstract

Allii Macrostemonis Bulbus (Xiebai in Chinese), as a famous traditional Chinese medicine, has great medicinal and dietary values since ancient times. In China, the dry bulbs of Allium macrostemon and Allium chinense are both used as its original plants. Pharmacological studies have revealed that both of them could increase plasminogen activator activity and prolong the effect of coagulation to achieve antiplatelet aggregation which validates their traditional uses for the treatment of thoracic obstruction and cardialgia in clinics. Besides, several other significant activities, including lipid-lowering, anti-atherosclerosis, antitumor, antispasmodic, antibacterial, antioxidant, and insecticidal activities, have already been reported. The volatile oils, nitrogenous compounds, and steroidal saponins are the major beneficial compounds. Among them, steroidal saponins are considered as the characteristic constituents. In this review, the current information concerning the phytochemistry and pharmacology of Allii Macrostemonis Bulbus is summarized comprehensively. In addition, several research future perspectives are presented, especially the mechanism of bioactive components and fraction from the bulbs of Allium macrostemon and Allium chinense.
Copyright © 2016 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allii Macrostemonis Bulbus; Allium chinense; Allium macrostemon; Future perspectives; Pharmacology; Phytochemistry

Mesh:

Substances:

Year:  2016        PMID: 27507199     DOI: 10.1016/S1875-5364(16)30058-9

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  4 in total

1.  Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation.

Authors:  Lu-Lu Yan; Wei-Yang Zhang; Xiao-Hong Wei; Li Yan; Chun-Shui Pan; Yang Yu; Jing-Yu Fan; Yu-Ying Liu; Hua Zhou; Jing-Yan Han; Xin-Sheng Yao
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

2.  Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.

Authors:  Yuan Liu; Xu He; Zhibiao Di; Xia Du
Journal:  ACS Omega       Date:  2022-01-28

3.  Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study.

Authors:  Wenhao Jia; Yan Li; Jie Wan; Xiaoyun Cui; Jinjin Lu; Jing Liu; Dong Li; Lei Li; Ting Zou; Junpin Ding; Qian Lin
Journal:  Cardiovasc Drugs Ther       Date:  2020-08       Impact factor: 3.727

4.  Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial.

Authors:  Guang Yang; Haoqiang He; Hongzheng Li; Zinuo Shen; Siyuan Zhou; Bingxu Lu; Jun Li; Qingyong He; Zhenpeng Zhang; Yongmei Liu; Jie Wang; Hengwen Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.